Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Feb 7, 2026
Date Accepted: Jul 31, 2026

The final, peer-reviewed published version of this preprint can be found here:

Evaluation of the Clinical Usefulness of a Bioartificial Urethral Substitute Generated by Tissue Engineering in Laboratory Rabbits: Protocol for an In Vivo Study

Sánchez-Porras D, Campos F, Chato-Astrain J, Alaminos M, Sánchez-Quevedo MC, Fernández-Valadés R

Evaluation of the Clinical Usefulness of a Bioartificial Urethral Substitute Generated by Tissue Engineering in Laboratory Rabbits: Protocol for an In Vivo Study

JMIR Res Protoc 2026;15:e93091

DOI: 10.2196/93091

PMID: 42901490

Evaluation of the clinical usefulness of a bioartificial urethral substitute generated by tissue engineering: an in vivo study protocol in laboratory rabbits

  • David Sánchez-Porras; 
  • Fernando Campos; 
  • Jesús Chato-Astrain; 
  • Miguel Alaminos; 
  • M. Carmen Sánchez-Quevedo; 
  • Ricardo Fernández-Valadés

ABSTRACT

Background:

The recent development of bioartificial tissues by tissue engineering allows the generation of multilayered urethra substitutes potentially useful for the clinical treatment of severe conditions affecting the human urethra.

Objective:

This study aims to evaluate biosafety and efficacy in laboratory animals of a multilayered artificial urethra generated by tissue engineering to determine its clinical potential as advanced therapies medicinal product.

Methods:

Five groups of study have been established, including a positive control group of native animals, a negative control group of animals in which the ventral side of the urethra will be surgically sectioned and left unrepaired, a gold-standard group in which the ventral side of the urethra will be surgically sectioned and repaired with an oral mucosa autograft, an acellular group in which the urethral defect will be repaired using a multilayered fibrin-agarose biomaterial and a group of animals in which a multilayered cellular bioartificial urethra will be used to repair the urethral defect. Animals will be followed for 3 months, and variables related to biosafety, functionality and histological structure of the urethral grafts will be determined.

Results:

This study was approved by the Ethics Committee for Animal Research (Junta de Andalucía), protocol code 17/12/2024/178; date of approval: 20 December 2024). The study began in February 2025, and it is expected to finish by July 2026.

Conclusions:

The present preclinical study will contribute to determining the potential usefulness of these bioartificial tissues as novel advanced therapies medicinal products for clinical use.


 Citation

Please cite as:

Sánchez-Porras D, Campos F, Chato-Astrain J, Alaminos M, Sánchez-Quevedo MC, Fernández-Valadés R

Evaluation of the Clinical Usefulness of a Bioartificial Urethral Substitute Generated by Tissue Engineering in Laboratory Rabbits: Protocol for an In Vivo Study

JMIR Res Protoc 2026;15:e93091

DOI: 10.2196/93091

PMID: 42901490

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.